Merck Presents New Phase 3 Data on Investigational Two-Drug HIV Regimen Doravirine/Islatravir (DOR/ISL) Showing Minimal Impact on Weight, Body Composition, and Lipid Levels Merck (NYSE: MRK), known as MSD outside…
Novo Nordisk Acquires Global Rights to Omeros’ MASP-3 Inhibitor Zaltenibart in $2.1 Billion Agreement Novo Nordisk and Omeros Corporation (Nasdaq: OMER) have entered into a definitive asset purchase and license…
WHO Warns of Global Neurological Health Crisis: Over 11 Million Deaths Annually Demand Urgent Action The World Health Organization (WHO) has issued a stark warning about the growing global burden…
WHO and European Union Join Forces to Advance Digital Health Systems Across Sub-Saharan Africa The World Health Organization (WHO) and the European Union (EU) have formally announced a new collaboration…
WHO Medical Product Alert N°5/2025: Identification of Substandard (Contaminated) Oral Liquid Medicines in the South-East Asia Region The World Health Organization (WHO) has issued Medical Product Alert N°5/2025 concerning the…
WHO Launches EIOS 2.0 to Strengthen Global Health Intelligence and Threat Detection The World Health Organization (WHO) today announced the official launch of version 2.0 of its Epidemic Intelligence from…
AbbVie to Present Comprehensive Data on Antibody-Drug Conjugate Portfolio at ESMO 2025, Reinforcing Leadership in Targeted Solid Tumor Therapies AbbVie (NYSE: ABBV) announced today that it will present a robust…
AbbVie Announces FDA Approval of Updated RINVOQ® (upadacitinib) Indication for Inflammatory Bowel Disease NORTH CHICAGO, Ill., Oct. 13, 2025 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food…
LEQEMBI® IQLIK™ Named One of TIME’s Best Inventions of 2025 for Transforming Alzheimer’s Treatment Access Eisai Co., Ltd. and Biogen Inc. today announced that LEQEMBI® IQLIK™ (lecanemab-irmb), the first subcutaneous…
UCB Publishes Final Analysis of Fintepla® Open-Label Extension Study in Lennox-Gastaut Syndrome Demonstrating Sustained Seizure Reduction and Improved Quality of Life UCB, a global biopharmaceutical company, announced that the final…
WuXi Biologics Applauds Sonoma Biotherapeutics Co-Founder Dr. Fred Ramsdell on Receiving the 2025 Nobel Prize in Physiology or Medicine WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing…
Neurology Publication Demonstrates 95% Reduction in Mortality Risk with Pyrimidine Nucleos(t)ide Therapy in Patients with Thymidine Kinase 2 Deficiency (TK2d) UCB, a global biopharmaceutical company focused on the discovery and…